Vote Now
Research Grants - 2010


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2010


To view an abstract, select an author from the vertical list on the left.

2010 Grants - Hetz

Defining the Role of the Unfolded Protein Response in Alzheimer's Disease

Claudio Hetz, Ph.D.
Institute of Biomedical Sciences, University of Chile
Santiago, Chile

2010 New Investigator Research Grant

Brain accumulations of the protein fragment beta-amyloid are thought to disrupt cell-to-cell communication and cause nerve cell death in Alzheimer's disease. But the mechanisms by which amyloid clumps exert their toxicity remain unclear. Recent studies have found that stress in the nerve cell's endoplasmic reticulum, a part of the cell where proteins are produced, may play a role in beta-amyloid toxicity. This stress appears to be caused by a chemical pathway, or series of chemical reactions, known as the unfolded protein response.

Claudio Hetz, Ph.D., and colleagues have been studying links between the unfolded protein response and amyloid toxicity. They have engineered mouse brain cells that lack a protein called x-box binding protein-1 (XBP-1), which promotes the unfolded protein response. Preliminary research has found that these cells can resist the effects of toxic beta-amyloid.

For their proposed grant, Dr. Hetz and colleagues will analyze how XBP-1 makes brain cells vulnerable to amyloid-induced damage. This effort will involve analysis of cultured brain cells and of several animal models engineered to develop Alzheimer-like symptoms. The researchers will also test whether XBP-1 makes Alzheimer-like mice susceptible to cognitive impairments.

The results of Dr. Hetz' study could shed new light on the mechanisms underlying beta-amyloid's role in Alzheimer's. The effort could also lead to new therapies for the disease.